Wan Jerry 4
4 · ACHIEVE LIFE SCIENCES, INC. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
ACHV: Principal Accounting Officer Jerry Wan Receives Stock Award
What Happened
Jerry Wan, Principal Accounting Officer of Achieve Life Sciences (ACHV), was granted a derivative award covering 70,300 shares on 2026-01-28. The Form 4 reports the acquisition at $0.00 (no cash paid by the insider at grant). This is a compensation award (not an open‑market purchase or sale).
Key Details
- Transaction date: 2026-01-28; Form 4 filed: 2026-01-30 (timely filing).
- Security/transaction: Grant (derivative award/option) for 70,300 shares; reported price $0.00.
- Vesting: Award vests 25% on the first anniversary (Jan 28, 2026) then in substantially equal monthly installments over the following 36 months (per footnote).
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- No indication of a 10b5-1 plan, tax withholding, cashless exercise, or late filing in the provided data.
Context
This filing reports a standard equity compensation grant to an executive. Such awards are common as part of pay/retention packages and do not represent an immediate open‑market purchase or sale. Because the award vests over time, economic ownership and any potential taxable event typically occur as portions vest or are exercised in the future.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-01-28+70,300→ 70,300 totalExercise: $4.36Exp: 2036-01-28→ Common Stock (70,300 underlying)
Footnotes (1)
- [F1]The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.